cas 1131-01-7|| where to buy 2-chloro-N-(2,6-dimethylphenyl)acetamide

製品名:2-chloro-N-(2,6-dimethylphenyl)acetamide

IUPAC Name:2-chloro-N-(2,6-dimethylphenyl)acetamide

包装単位	有効在庫	価格（USD）
CM114010-100g	in stock	ŮǸ
CM114010-500g	in stock	ħǪǸ

研究開発用専用.

問い合わせフォーム

化学物質名

CAS番号

数量*

要求仕様*
（アッセイ %、材料グレード等）

お名前*

連絡先Eメールアドレス*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1131-01-7 regularly via the above email.

追記事項

Verification code*

refresh

: CAS番号:1131-01-7; 分子式:C10H12ClNO; 融点:-; SMILESコード:O=C(NC1=C(C)C=CC=C1C)CCl; 密度:

: カタログ番号:CM114010; 分子量:197.66; 沸点:; MDL番号:MFCD00000926; 保管方法:

: Benzenes; Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

: Taplucainium chloride; Nocion Therapeutics presents data on preclinical and clinical development of Taplucainium, a novel, charged sodium channel blocker, as a potential treatment for chronic cough at the 13th London International Cough Symposium.
Taplucainium is a proprietary molecule in the novel class of charged sodium channel blockers that allows for specific silencing of activated/inflamed nociceptors while having minimal local off-target effects or systemic exposure. Unlike other investigative cough therapies, such as P2X3-antagonists, TRPA1-antagonists and TRPM8-agonists, which target a specific large pore channel, taplucainium works downstream by selectively targeting the sodium channels in activated nociceptors which are the target of these large pore channels.